# An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome

> **NCT02023424** · PHASE1 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Rett Syndrome

## Interventions

- **DRUG:** Glatiramer Acetate (Copaxone®)

## Key facts

- **NCT ID:** NCT02023424
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2014-09
- **Final completion:** 2015-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023424, "An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02023424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*